Multicenter safety study of perilesional application of CIGB-128A in skin carcinomas eyelid with surgical risk and aesthetic implications.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Interferon-alpha-2b/interferon-gamma (Primary)
- Indications Skin cancer
- Focus Adverse reactions
- Acronyms SCIENCE
- 06 Sep 2016 Status changed from planning to not yet recruiting.
- 18 Feb 2013 New trial record